What Is Etcamah, and How Does It Work? The FDA has approved Etcamah (camizestrant) to treat adults with advanced breast cancer. It is used for tumors that are hormone receptor (HR)-positive and human epidermal growth… Read more
What Is Hyrnuo and How Does It Work? The FDA has granted accelerated approval to Hyrnuo (sevabertinib) for adults with a specific type of advanced lung cancer. It is used for non-squamous non-small-cell lung cancer… Read more
What Is Kerendia and How Does It Work? The FDA has approved Kerendia (finerenone) for adults who have chronic kidney disease (CKD) linked to type 1 diabetes. CKD is a condition where the kidneys slowly… Read more
What Is Fayuvi and How Does It Work? The FDA has approved Fayuvi (rebisufligene etisparvovec) to treat brain-related symptoms in children with a rare genetic disease called Sanfilippo syndrome type A, also known as mucopolysaccharidosis… Read more
Are ‘Wet Dreams’ Normal and Healthy? Nocturnal emissions are a natural part of growing up and nothing to worry about available to view online. In fact, some areas may be noticeably up and active.… Read more
The FDA has approved a new combination treatment for adults with certain cancers of the blood and lymphatic system. The targeted regimen combines Calquence (acalabrutinib) tablets with Venclexta (venetoclax) for adults with previously untreated chronic lymphocytic… Read more
Yuviwel (navepegritide) is a once-weekly shot for children 2 and older with achondroplasia who still have open growth plates. It is approved by the FDA to help increase height in this group. Yuviwel is a… Read more
Wakix (pitolisant) is a prescription medication used to treat narcolepsy, a long-term neurological sleep disorder that causes excessive daytime sleepiness and, in many cases, cataplexy (sudden muscle weakness triggered by strong emotions). The FDA has… Read more
Darzalex Faspro is an injectable medicine used to treat adults with multiple myeloma, a type of blood cancer, and light chain (AL) amyloidosis, a rare condition caused by the buildup of abnormal proteins in organs.… Read more
Yartemlea (narsoplimab-wuug) is a new medicine approved by the FDA for treating a rare and serious condition called transplant-associated thrombotic microangiopathy (TA-TMA) in adults and children ages 2 years or older. TA-TMA is a serious… Read more